reference/14014658

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14014658

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	740
issn	0923-7534
issueIdentifier	4
pageRange	734-740
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	734
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2ea80026665e031b7380448129ca3b62 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_62ba0234a5f1a9d27ab0e1ae42649ffd
bibliographicCitation	Paiva CE, Drigo SA, Rosa FE, Moraes Neto FA, Caldeira JRF, Soares FA, Domingues MAC, Rogatto SR. Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours. Ann Oncol. 2010 Apr;21(4):734–40. doi: 10.1093/annonc/mdp518. PMID: 19914962.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c0a9a1a21084c9b5ebfeb079af00397 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12d6a40ee10f506e86695f3eda7ac9e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38a71a5a0954460236f21d358c8ae626 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26a133aab8b3dea94dec0f7b98e0b9e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f3fa72bae15abcfae2b96eac1453fcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7c6ed73c9c2e6ee6cc4f98777a7ff34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_734b883062cc5fae318338a4ea564569 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbf3288230d06957dfe4b1491f1a4aa4
date	201004
identifier	https://pubmed.ncbi.nlm.nih.gov/19914962 https://doi.org/10.1093/annonc/mdp518
isPartOf	https://portal.issn.org/resource/ISSN/0923-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0027330 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M0024760 http://id.nlm.nih.gov/mesh/M0215077
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018734 http://id.nlm.nih.gov/mesh/D002277Q000175 http://id.nlm.nih.gov/mesh/D001943Q000175 http://id.nlm.nih.gov/mesh/D017346Q000235 http://id.nlm.nih.gov/mesh/D018125Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D002277Q000235 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D001943Q000401 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D002277Q000401 http://id.nlm.nih.gov/mesh/D014408Q000032 http://id.nlm.nih.gov/mesh/D053773Q000235 http://id.nlm.nih.gov/mesh/D002277Q000378 http://id.nlm.nih.gov/mesh/D015536 http://id.nlm.nih.gov/mesh/D017346Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077294 http://id.nlm.nih.gov/mesh/D018125Q000378 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D011237
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7048

Total number of triples: 68.